Thiazide diuretics alone or with beta-blockers impair glucose metabolism in hypertensive patients with abdominal obesity.
Manrique
Camila
C
Johnson
Megan
M
Sowers
James R
JR
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D001262:Atenolol / Q000009:adverse effects / Q000627:therapeutic use*; D003920:Diabetes Mellitus / Q000139:chemically induced; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005215:Fasting / Q000097:blood; D006801:Humans; D006852:Hydrochlorothiazide / Q000009:adverse effects / Q000627:therapeutic use*; D006943:Hyperglycemia / Q000097:blood / Q000139:chemically induced; D006973:Hypertension / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D015228:Hypertriglyceridemia / Q000097:blood / Q000139:chemically induced; D033461:Hyperuricemia / Q000139:chemically induced; D008075:Lipoproteins, HDL / Q000097:blood; D008659:Metabolic Diseases / Q000139:chemically induced; D056128:Obesity, Abdominal / Q000503:physiopathology*
D000319:Adrenergic beta-Antagonists; D004232:Diuretics; D008075:Lipoproteins, HDL; D006852:Hydrochlorothiazide; D001262:Atenolol